0QAH Stock Financial Analysis - Merck & Co., Inc. (LSE) Stock

Overview

Merck & Co., Inc., based in the United States, is a prominent global healthcare company that primarily operates in the pharmaceutical industry. The company is dedicated to the discovery, development, manufacture, and marketing of a wide range of innovative health solutions. Its portfolio includes prescription medicines, vaccines, biologic therapies, and animal health products. Merck & Co., Inc. is engaged in key projects that focus on oncology, infectious diseases, and vaccines, reflecting its commitment to addressing some of the most urgent medical challenges. Through its research and development efforts, Merck aims to sustain its leadership in these areas, ensuring continuous improvement in healthcare outcomes globally.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Merck & Co., Inc. as of 30 June 2025 is 63,616.00 MM.
The operating income for Merck & Co., Inc. as of 30 June 2025 is 23,948.00 MM.
The net income for Merck & Co., Inc. as of 30 June 2025 is 16,406.00 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	63,616.00	23,948.00	16,406.00
2025-03-31	63,922.00	24,411.00	17,434.00
2024-12-31	64,168.00	24,889.00	17,117.00
2024-09-30	63,174.00	16,794.00	12,148.00
2024-06-30	62,480.00	18,637.00	13,736.00
2024-03-31	61,403.00	17,530.00	2,306.00
2023-12-31	60,115.00	15,974.00	365.00
2023-09-30	59,315.00	20,957.00	4,608.00
2023-06-30	58,311.00	19,883.00	3,111.00
2023-03-31	57,869.00	19,816.00	13,030.00
2022-12-31	59,283.00	20,490.00	14,519.00
2022-09-30	58,974.00	19,761.00	15,260.00
2022-06-30	57,169.00	19,482.00	16,579.00
2022-03-31	53,978.00	18,123.00	14,180.00
2021-12-31	48,704.00	13,893.00	13,049.00
2021-09-30	46,131.00	13,635.00	7,197.00
2021-06-30	43,906.00	12,298.00	5,570.00
2021-03-31	41,857.00	11,071.00	7,027.00
2020-12-31	41,518.00	10,395.00	7,067.00
2020-09-30	42,438.00	12,522.00	11,517.00
2020-06-30
2020-03-31

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	6.76	6.74
2024-09-30	4.79	4.78
2024-06-30	5.42	5.39
2024-03-31	0.91	0.90
2023-12-31	0.14	0.14
2023-09-30	1.82	1.80
2023-06-30	1.23	1.23
2023-03-31	5.14	5.12
2022-12-31	5.73	5.71
2022-09-30	6.03	6.01
2022-06-30	6.56	6.53
2022-03-31	5.61	5.59
2021-12-31	5.16	5.14
2021-09-30	2.84	2.84
2021-06-30	2.20	2.20
2021-03-31	2.78	2.77
2020-12-31	2.79	2.78
2020-09-30	4.55	4.53
2020-06-30	4.12	4.10
2020-03-31	3.98	3.95

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Merck & Co., Inc. as of 30 June 2025 is 18,534.00 MM.
The cash from investing activities for Merck & Co., Inc. as of 30 June 2025 is -7,546.00 MM.
The cash from financing activities for Merck & Co., Inc. as of 30 June 2025 is -14,745.00 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	18,534.00	-7,546.00	-14,745.00
2025-03-31	20,878.00	-7,845.00	-9,973.00
2024-12-31	21,468.00	-7,734.00	-7,032.00
2024-09-30	18,264.00	-6,237.00	-6,268.00
2024-06-30	16,690.00	-2,726.00	-8,112.00
2024-03-31	14,757.00	-13,100.00	-5,570.00
2023-12-31	13,006.00	-14,083.00	-4,810.00
2023-09-30	17,190.00	-15,884.00	-4,119.00
2023-06-30	15,075.00	-16,512.00	-2,552.00
2023-03-31	15,673.00	-6,146.00	-8,087.00
2022-12-31	19,095.00	-4,960.00	-9,119.00
2022-09-30	19,696.00	-15,261.00	-2,358.00
2022-06-30	18,891.00	-15,360.00	-1,930.00
2022-03-31	17,220.00	-16,990.00	1,605.00
2021-12-31	14,109.00	-16,555.00	2,593.00
2021-09-30	13,072.00	-9,284.00	-1,242.00
2021-06-30	11,897.00	-11,827.00	-2,819.00
2021-03-31	11,184.00	-8,553.00	-3,440.00
2020-12-31	10,241.00	-9,443.00	-2,832.00
2020-09-30	11,041.00	-5,428.00	-6,215.00
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/e for Merck & Co., Inc. as of 30 June 2025 is 11.39.
The p/book for Merck & Co., Inc. as of 30 June 2025 is 4.28.
The p/tbv for Merck & Co., Inc. as of 30 June 2025 is 23.99.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30	11.39	4.28	23.99
2025-03-31	13.21	5.07	34.66
2024-12-31	20.82	5.80	51.20
2024-09-30	21.02	7.14	126.68
2024-06-30
2024-03-31	579.85	5.12	101.17
2023-12-31	46.00	5.47	-129.24
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30	46.43	9.56	-47.40
2021-03-31	36.78	9.56	-34.12
2020-12-31	36.56	10.17	-27.37
2020-09-30	22.42	8.82	-33.74
2020-06-30	24.64	9.31	-29.05
2020-03-31	25.40	9.91	-26.13

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for Merck & Co., Inc. as of 30 June 2025 is 0.09.
The ebit (3y)/ev for Merck & Co., Inc. as of 30 June 2025 is 0.06.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30	0.09	0.06
2025-03-31	0.08	0.05
2024-12-31	0.05	0.04
2024-09-30	0.05	0.04
2024-06-30
2024-03-31	0.01	0.04
2023-12-31	0.03	0.05
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30	0.03	0.04
2021-03-31	0.03	0.04
2020-12-31	0.02	0.03
2020-09-30	0.04	0.04
2020-06-30	0.05	0.04
2020-03-31	0.04	0.03

Management Effectiveness

The roa for Merck & Co., Inc. as of 30 June 2025 is 0.15.
The roe for Merck & Co., Inc. as of 30 June 2025 is 0.41.
The roic for Merck & Co., Inc. as of 30 June 2025 is 0.21.
The croic for Merck & Co., Inc. as of 30 June 2025 is 0.04.
The ocroic for Merck & Co., Inc. as of 30 June 2025 is 0.25.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.15	0.41	0.21	0.04	0.25
2025-03-31	0.16	0.45	0.21	0.08	0.26
2024-12-31	0.11	0.41	0.15	0.07	0.22
2024-09-30	0.13	0.31	0.18	0.07	0.21
2024-06-30	0.02	0.05	0.03	-0.06	0.20
2024-03-31	0.00	0.01	0.00	-0.08	0.17
2023-12-31	0.04	0.11	0.06	-0.04	0.23
2023-09-30	0.03	0.08	0.04	-0.05	0.18
2023-06-30	0.12	0.08	0.04	-0.05	0.19
2023-03-31	0.14	0.34	0.17	0.02	0.20
2022-12-31	0.16	0.46	0.21	0.02	0.27
2022-09-30	0.18	0.46	0.20	0.02	0.26
2022-06-30	0.16	0.61	0.22	0.01	0.25
2022-03-31	0.14	0.52	0.19	0.02	0.24
2021-12-31	0.08	0.51	0.20	0.00	0.22
2021-09-30	0.08	0.25	0.12	0.04	0.20
2021-06-30	0.06	0.20	0.11	-0.05	0.21
2021-03-31	0.08	0.27	0.11	-0.01	0.18
2020-12-31	0.08	0.26	0.11	-0.03	0.16
2020-09-30	0.14	0.42	0.20	-0.01	0.17
2020-06-30	0.12	0.38	0.19	0.08	0.24
2020-03-31	0.12	0.38	0.18	-0.01	0.22

Gross Margins

The gross margin for Merck & Co., Inc. as of 30 June 2025 is 0.77.
The net margin for Merck & Co., Inc. as of 30 June 2025 is 0.27.
The operating margin for Merck & Co., Inc. as of 30 June 2025 is 0.38.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.77	0.27	0.38
2025-03-31	0.81	0.27	0.37
2024-12-31	0.77	0.19	0.44
2024-09-30	0.76	0.22	0.47
2024-06-30	0.75	0.04	0.29
2024-03-31	0.77	0.01	0.29
2023-12-31	0.73	0.08	0.16
2023-09-30	0.73	0.05	0.15
2023-06-30	0.73	0.05	0.15
2023-03-31	0.74	0.23	0.32
2022-12-31	0.74	0.26	0.38
2022-09-30	0.71	0.26	0.38
2022-06-30	0.71	0.29	0.35
2022-03-31	0.76	0.26	0.34
2021-12-31	0.73	0.27	0.37
2021-09-30	0.72	0.14	0.34
2021-06-30	0.72	0.11	0.31
2021-03-31	0.72	0.15	0.30
2020-12-31	0.72	0.17	0.34
2020-09-30	0.72	0.26	0.31
2020-06-30	0.72	0.22	0.32
2020-03-31	0.71	0.22	0.35

MX:MRK
IT:1MRKX	€72.40
PE:MRK
CH:010683053
AT:MRK
DE:6MK	€71.80
US:MRK	US$84.71
GB:6MKD
BG:6MK
CL:MRK
CL:MRKCL